Provided By GlobeNewswire
Last update: Aug 8, 2024
WINCHESTER, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the second quarter 2024 and provided a corporate update.
Read more at globenewswire.comNASDAQ:SYBX (8/22/2025, 8:00:00 PM)
1.46
+0.06 (+4.29%)
Find more stocks in the Stock Screener